Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EmbryoGlue in IVF Treatment Cycles
NCT03332680Completed
- Sponsor
- University of Oxford
- Start
- Jun 2017
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of EmbryoGlue in infertility (2 arms), sponsored by University of Oxford. Primary endpoint: Live Birth Rate at 9 months. Started Jun 2017; status: completed.
02
Drugs
EmbryoGlue
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03332680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03332680.